Cross Country Healthcare agrees to USD 437 million buyout by Knox Lane for USD 13.25/share

Cross Country Healthcare, Inc.

CCRN

0.00

Knox Lane agreed to buy Cross Country Healthcare for USD 13.25 per share in cash, valuing deal at USD 437 million.
Offer implies about 31% premium to May 6, 2026 close, about 45% premium to 90-day volume-weighted average price through May 6, 2026.
Transaction expected to close in Q3 2026, subject to stockholder vote, required regulatory approvals.
Cross Country Healthcare expected to become privately held, delist from Nasdaq upon closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cross Country Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605061732BIZWIRE_USPR_____20260506_BW144806) on May 06, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.